|Articles|October 4, 2022
Almac Announces New Cryogenic Service Solution
New solution within Durham, North Carolina campus will support cell and gene therapies.
Advertisement
Almac Clinical Services announced a new Cryogenic Service Solution within its Durham, North Carolina campus to support cell and gene therapies.
This latest investment from Almac adds to the company’s overall $4m investment to date in innovative cold chain technology in North Carolina.
Read more about the new solution
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Outlines New Superiority Standard for Future CAR-T Approvals
2
2025 Veeva R&D and Quality Summit: Advancing Site Efficiency and Collaboration in the Next Era of Clinical Trials
3
ACT Brief: New CAR-T Trial Requirements, Pfizer Advances Oral GLP-1 Strategy, and Kisqali Shows Durable Long-Term Control
4
ACT Brief: Governance-Driven eCOA Acceleration, Site Operations Innovation, and New Momentum for Earlier CAR-T
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
